We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases

Press releases

Novasep announces the launch of a consent solicitation for the maturity extension of notes with requisite voting majority of the noteholders already secured

31 Jan 2019

Novasep Holding S.A.S (“Novasep”), a leading supplier of services and technologies for the life sciences industry, announces the launch of a consent solicitation (the “Consent Solicitation”) in order to, inter alia:


Novasep industrializes potato protein purification unit for Solanic B.V.

Novasep industrializes potato protein purification unit for Solanic B.V.

22 Oct 2018

This represents a step forward for the plant-based protein purification industry, with the first compact bed chromatography system for the purification of vegetable proteins.


Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

21 Aug 2018

Novasep’s robust quality assurance system, fully compliant with the highest world standards, showcased during successful FDA inspection of the Chasse-sur-Rhône (France) facility.


Novasep launches BioSC® Pilot, breakthrough chromatography and DSP skid for biologics purification

11 Jun 2018

BioSC Pilot® is a new tool for continuous and intensified downstream processes in the biopharmaceutical industry.


Novasep announces 2017 financial results

Novasep announces 2017 financial results

25 Apr 2018

Sales are up 4% at 282 M€
EBITDA is up 4.3% at 29 M€


Novasep supplies Complete Process Line to MEFSCO corn milling facility

Novasep supplies Complete Process Line to MEFSCO corn milling facility

06 Mar 2018

The starch sweeteners plant will serve the growing Middle Eastern food and beverage market.


Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API

Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API

12 Dec 2017

The manufacturing will take place at Novasep’s Chasse sur Rhône site.


Novasep supplies MENA sugar industry leader, Al Nouran

Novasep supplies MENA sugar industry leader, Al Nouran

23 Nov 2017

• Egyptian producer Al Nouran’s future sugar production facility integrates Novasep-engineered purification units
• The new plant to address local supply shortage


Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity

Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity

24 Oct 2017

Novasep announces €4M investment to install a new cryogenics production line and a new pilot stream at its Chasse-sur-Rhône (FR) facility


Novasep becomes an Authorized Economic Operator (AEO)

Novasep becomes an Authorized Economic Operator (AEO)

06 Oct 2017

Novasep fully compliant with the most stringent international supply chain standards



You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!